• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障:在神经系统疾病中,对中枢神经系统稳态破坏的促成作用大于受害者。

Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders.

作者信息

Xiao Minjia, Xiao Zhi Jie, Yang Binbin, Lan Ziwei, Fang Fang

机构信息

Department of Neurology, Second Xiangya Hospital, Central South University, Changsha, China.

Department of Critical Care Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Front Neurosci. 2020 Aug 6;14:764. doi: 10.3389/fnins.2020.00764. eCollection 2020.

DOI:10.3389/fnins.2020.00764
PMID:32903669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7438939/
Abstract

The blood-brain barrier (BBB) is a dynamic but solid shield in the cerebral microvascular system. It plays a pivotal role in maintaining central nervous system (CNS) homeostasis by regulating the exchange of materials between the circulation and the brain and protects the neural tissue from neurotoxic components as well as pathogens. Here, we discuss the development of the BBB in physiological conditions and then focus on the role of the BBB in cerebrovascular disease, including acute ischemic stroke and intracerebral hemorrhage, and neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Finally, we summarize recent advancements in the development of therapies targeting the BBB and outline future directions and outstanding questions in the field. We propose that BBB dysfunction not only results from, but is causal in the pathogenesis of neurological disorders; the BBB is more a contributor to the disruption of CNS homeostasis than a victim in neurological disorders.

摘要

血脑屏障(BBB)是脑微血管系统中一个动态但坚固的屏障。它通过调节循环系统与大脑之间的物质交换,在维持中枢神经系统(CNS)内环境稳定方面发挥着关键作用,并保护神经组织免受神经毒性成分以及病原体的侵害。在此,我们将讨论生理条件下血脑屏障的发育,然后重点关注血脑屏障在脑血管疾病(包括急性缺血性中风和脑出血)以及神经退行性疾病(如阿尔茨海默病(AD)、帕金森病(PD)和多发性硬化症(MS))中的作用。最后,我们总结了针对血脑屏障治疗方法开发的最新进展,并概述了该领域未来的方向和悬而未决的问题。我们认为,血脑屏障功能障碍不仅是神经疾病发病机制的结果,而且在其中起因果作用;在神经疾病中,血脑屏障更多地是中枢神经系统内环境稳定破坏的促成因素,而非受害者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/6ff88caa1892/fnins-14-00764-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/6f1a6290ae97/fnins-14-00764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/0aba839fa215/fnins-14-00764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/dd4645fd141d/fnins-14-00764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/6ff88caa1892/fnins-14-00764-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/6f1a6290ae97/fnins-14-00764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/0aba839fa215/fnins-14-00764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/dd4645fd141d/fnins-14-00764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/7438939/6ff88caa1892/fnins-14-00764-g004.jpg

相似文献

1
Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders.血脑屏障:在神经系统疾病中,对中枢神经系统稳态破坏的促成作用大于受害者。
Front Neurosci. 2020 Aug 6;14:764. doi: 10.3389/fnins.2020.00764. eCollection 2020.
2
Blood-Brain Barrier: From Physiology to Disease and Back.血脑屏障:从生理学、疾病到治疗。
Physiol Rev. 2019 Jan 1;99(1):21-78. doi: 10.1152/physrev.00050.2017.
3
Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects.神经疾病的机制见解、治疗模式和临床进展:现状与未来展望。
Int J Mol Sci. 2023 Jan 10;24(2):1340. doi: 10.3390/ijms24021340.
4
The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases.静脉内给药纳米颗粒在中风和与年龄相关的神经退行性疾病中的治疗益处。
Curr Pharm Des. 2022;28(24):1985-2000. doi: 10.2174/1381612828666220608093639.
5
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB.固体脂质纳米粒(SLNs):一种通过血脑屏障靶向脑部的先进药物递送系统。
Pharmaceutics. 2021 Jul 31;13(8):1183. doi: 10.3390/pharmaceutics13081183.
6
Revealing the mechanisms of blood-brain barrier in chronic neurodegenerative disease: an opportunity for therapeutic intervention.揭示慢性神经退行性疾病中血脑屏障的机制:治疗干预的机会。
Rev Neurosci. 2024 Jul 8;35(8):895-916. doi: 10.1515/revneuro-2024-0040. Print 2024 Dec 17.
7
Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.星形胶质细胞对血脑屏障的调节:帕金森病的研究视角。
Front Cell Neurosci. 2014 Aug 4;8:211. doi: 10.3389/fncel.2014.00211. eCollection 2014.
8
The role of the blood-brain barrier during neurological disease and infection.血脑屏障在神经疾病和感染中的作用。
Biochem Soc Trans. 2023 Apr 26;51(2):613-626. doi: 10.1042/BST20220830.
9
Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System.治疗性抑制中枢神经系统疾病中的补体系统。
Front Immunol. 2019 Mar 4;10:362. doi: 10.3389/fimmu.2019.00362. eCollection 2019.
10
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.血脑屏障功能障碍与阿尔茨海默病发病机制。
Int J Mol Sci. 2017 Sep 13;18(9):1965. doi: 10.3390/ijms18091965.

引用本文的文献

1
Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications.铁死亡与铁稳态:分子机制及对神经退行性疾病的影响
Antioxidants (Basel). 2025 Apr 28;14(5):527. doi: 10.3390/antiox14050527.
2
Blood-brain barrier integrity disruption is associated with both chronic vascular risk factors and white matter hyperintensities.血脑屏障完整性破坏与慢性血管危险因素和白质高信号均相关。
J Prev Alzheimers Dis. 2025 Feb;12(2):100029. doi: 10.1016/j.tjpad.2024.100029. Epub 2025 Jan 1.
3
The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

本文引用的文献

1
Immuno-metabolic impact of the multiple sclerosis patients' sera on endothelial cells of the blood-brain barrier.多发性硬化症患者血清对血脑屏障内皮细胞的免疫代谢影响。
J Neuroinflammation. 2020 May 9;17(1):153. doi: 10.1186/s12974-020-01810-8.
2
Ozanimod: First Approval.奥扎尼莫德:首次获批
Drugs. 2020 Jun;80(8):841-848. doi: 10.1007/s40265-020-01319-7.
3
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.载脂蛋白 E4 导致血脑屏障功能障碍,预测认知能力下降。
血脑屏障在神经退行性疾病中的关键作用:破坏机制及治疗意义
J Clin Med. 2025 Jan 9;14(2):386. doi: 10.3390/jcm14020386.
4
Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1β-independent neutrophil chemotaxis upon peripheral inflammation in mice.在小鼠外周炎症时,小胶质细胞NLRP3- Gasdermin D激活通过不依赖白细胞介素-1β的中性粒细胞趋化作用损害血脑屏障完整性。
Nat Commun. 2025 Jan 15;16(1):699. doi: 10.1038/s41467-025-56097-1.
5
Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases.氧化应激在血脑屏障破坏和神经退行性疾病中的作用
Antioxidants (Basel). 2024 Nov 28;13(12):1462. doi: 10.3390/antiox13121462.
6
Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC.揭示严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白对新冠后综合征(PASC)神经系统长期影响的奥秘。
Front Cell Neurosci. 2024 Dec 18;18:1481963. doi: 10.3389/fncel.2024.1481963. eCollection 2024.
7
Immune cell infiltration and modulation of the blood-brain barrier in a guinea pig model of tuberculosis: Observations without evidence of bacterial dissemination to the brain.豚鼠结核病模型中免疫细胞浸润及血脑屏障的调节:未观察到细菌播散至脑的证据
PLoS One. 2024 Dec 31;19(12):e0307577. doi: 10.1371/journal.pone.0307577. eCollection 2024.
8
The Involvement of Glial Cells in Blood-Brain Barrier Damage in Neuroimmune Diseases.神经免疫疾病中胶质细胞对血脑屏障损伤的作用
Int J Mol Sci. 2024 Nov 17;25(22):12323. doi: 10.3390/ijms252212323.
9
Psychobiotic Properties of in Neurodegenerative Diseases.在神经退行性疾病中的精神益生菌特性。
Int J Mol Sci. 2024 Aug 31;25(17):9489. doi: 10.3390/ijms25179489.
10
Research progress on high-concentration oxygen therapy after cerebral hemorrhage.脑出血后高浓度氧疗的研究进展
Front Neurol. 2024 Jul 29;15:1410525. doi: 10.3389/fneur.2024.1410525. eCollection 2024.
Nature. 2020 May;581(7806):71-76. doi: 10.1038/s41586-020-2247-3. Epub 2020 Apr 29.
4
Risk factor for Alzheimer's disease breaks the blood-brain barrier.阿尔茨海默病的风险因素会破坏血脑屏障。
Nature. 2020 May;581(7806):31-32. doi: 10.1038/d41586-020-01152-8.
5
Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles.靶向和穿越血脑屏障的细胞外囊泡。
Cells. 2020 Apr 1;9(4):851. doi: 10.3390/cells9040851.
6
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification.双等位基因 JAM2 变异导致早发性常染色体隐性遗传性原发性家族性脑钙化。
Am J Hum Genet. 2020 Mar 5;106(3):412-421. doi: 10.1016/j.ajhg.2020.02.007.
7
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?对于接受那他珠单抗治疗的多发性硬化症患者,哪种是最佳的 PML 风险分层策略?
Mult Scler Relat Disord. 2020 Jun;41:102008. doi: 10.1016/j.msard.2020.102008. Epub 2020 Feb 13.
8
Therapeutic drugs modulate ATP-Binding cassette transporter-mediated transport of amyloid beta in brain microvascular endothelial cells.治疗药物调节脑微血管内皮细胞中 ATP 结合盒转运蛋白介导的淀粉样β转运。
Eur J Pharmacol. 2020 May 5;874:173009. doi: 10.1016/j.ejphar.2020.173009. Epub 2020 Feb 13.
9
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients.多发性硬化症患者使用芬戈莫德、那他珠单抗和利妥昔单抗的癌症风险。
Ann Neurol. 2020 May;87(5):688-699. doi: 10.1002/ana.25701. Epub 2020 Mar 9.
10
Ketone Bodies Promote Amyloid-β Clearance in a Human in Vitro Blood-Brain Barrier Model.酮体促进人离体血脑屏障模型中淀粉样β清除。
Int J Mol Sci. 2020 Jan 31;21(3):934. doi: 10.3390/ijms21030934.